Assembly Biosciences Inc to Discuss HBV Portfolio Progress Call Transcript
Good afternoon. And welcome to the Assembly Biosciences' HBV Portfolio Progress Conference Call. (Operator Instructions)
As a reminder, this conference call is being recorded. I would now like to hand the call over to Amy Figueroa, Interim Investor Relations Consultant for Assembly. Please go ahead.
Good afternoon. And thank you for joining us as we discuss the recent progress with Assembly's portfolio of clinical stage core inhibitors, which are advancing in development for the treatment of patients with chronic hepatitis B infection.
This afternoon, we issued a press release reporting our financial results for the first quarter of 2020 and providing a corporate update. This press release and the slides we will refer to during the call are available in the News and Events section of our corporate website at www.assemblybio.com. After our prepared remarks, a PDF of the slides will be available from our website. Also, a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
